- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Melanoma in United States
Total 4406 results
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV MelanomaUnited States
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
Mannkind CorporationCompletedAdvanced Melanoma | Stage III and IV MelanomaUnited States
-
University of Michigan Rogel Cancer CenterRecruitingMetastatic Melanoma | Liver Metastases | Melanoma, Mucosal | Melanoma, Ocular | Melanoma, CutaneousUnited States
-
Roswell Park Cancer InstituteCompletedStage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IB Skin MelanomaUnited States
-
Taiga Biotechnologies, Inc.RecruitingStage IV Melanoma | Stage III MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNewly Diagnosed or Recurrent Metastatic Melanoma Patients | Malignant Brain TumorsUnited States
-
Spirita Oncology, LLCUniversity of ArizonaTerminatedBrain Metastases | Malignant MelanomaUnited States
-
PlexxikonRoche Pharma AGCompletedColorectal Carcinoma | Malignant MelanomaUnited States, Australia
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Melanoma | Stage IV MelanomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkCompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); University of Pennsylvania; RTI International; ITX CorporationCompletedMelanoma and Other Malignant Neoplasms of SkinUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
William CarsonSchering-PloughCompletedStage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage IIA Skin Melanoma | Stage IIB Skin Melanoma | Stage IIC Skin Melanoma | Stage IIIA Skin Melanoma | Stage IA Skin Melanoma | Stage IB Skin MelanomaUnited States
-
National Cancer Institute (NCI)SuspendedClinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
CINJRegulatoryNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Skin Melanoma | Recurrent MelanomaUnited States
-
Eisai Inc.TerminatedUnresectable Stage III Melanoma | Wild Type BRAF Stage IV MelanomaUnited States
-
Mannkind CorporationTerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Eisai Inc.RecruitingMelanoma, UvealUnited States
-
Providence Health & ServicesPrometheus LaboratoriesActive, not recruitingMetastatic MelanomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; National Cancer Institute (NCI); MedarexCompleted
-
OHSU Knight Cancer InstituteCompleted
-
F. Stephen Hodi, MDMedImmune LLCCompletedMetastatic MelanomaUnited States
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Completed
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics...CompletedMetastatic MelanomaUnited States
-
Western Regional Medical CenterTerminated
-
New England Retina AssociatesCompletedChoroidal MelanomaUnited States
-
New England Retina AssociatesGenentech, Inc.CompletedChoroidal MelanomaUnited States
-
University of Massachusetts, WorcesterCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular MelanomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
New England Retina AssociatesCompleted
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
Molecular Insight Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage III Melanoma | Extraocular Extension MelanomaUnited States
-
University of ChicagoMerck Sharp & Dohme LLC; Evelo Biosciences, Inc.Suspended
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaMetastatic MelanomaUnited States
-
Abramson Cancer Center at Penn MedicineImaginAb, Inc.Enrolling by invitation